Literature DB >> 15557519

Late-onset optic pathway tumors in children with neurofibromatosis 1.

R Listernick1, R E Ferner, L Piersall, S Sharif, D H Gutmann, J Charrow.   

Abstract

Identification of new optic pathway tumors (OPTs) and progression of pre-existing OPTs in children with neurofibromatosis 1 (NF1) have been reported infrequently after age 6. The authors present eight children with NF1 (mean age 12.2 years) seen in three NF1 centers who had either late-onset (four of eight) or late-progressive (seven of eight) OPT. Continued monitoring of individuals with NF1 into adulthood for the development of OPTs and for progression of known OPTs is warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15557519     DOI: 10.1212/01.wnl.0000144341.16830.01

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

Review 1.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

2.  Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.

Authors:  Mahendranath Moharir; Kevin London; Robert Howman-Giles; Kathryn North
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-24       Impact factor: 9.236

3.  'Double midbrain' sign in extensive optic pathway glioma in neurofibromatosis-1.

Authors:  Puneet Jain; Rachna Sehgal; Lakshminarayanan Kannan; Atin Kumar; Sheffali Gulati
Journal:  Indian J Pediatr       Date:  2013-08-14       Impact factor: 1.967

4.  Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.

Authors:  Eric Legius; Hilde Brems
Journal:  Childs Nerv Syst       Date:  2020-06-29       Impact factor: 1.475

5.  Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1.

Authors:  D H Gutmann; R Listernick; R E Ferner
Journal:  Eye (Lond)       Date:  2011-01-28       Impact factor: 3.775

6.  Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Authors:  Michael J Fisher; Michael Loguidice; David H Gutmann; Robert Listernick; Rosalie E Ferner; Nicole J Ullrich; Roger J Packer; Uri Tabori; Robert O Hoffman; Simone L Ardern-Holmes; Trent R Hummel; Darren R Hargrave; Eric Bouffet; Joel Charrow; Larissa T Bilaniuk; Laura J Balcer; Grant T Liu
Journal:  Neuro Oncol       Date:  2012-04-03       Impact factor: 12.300

Review 7.  MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma.

Authors:  Simona Gaudino; Matia Martucci; Rosellina Russo; Emiliano Visconti; Emma Gangemi; Francesco D'Argento; Tommaso Verdolotti; Libero Lauriola; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2016-10-18       Impact factor: 1.475

Review 8.  Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Authors:  Daphna Mezad-Koursh; Anat Bachar Zipori; Dinah Zur; Lior Degabli; Meital Ben-Dov; Ainat Klein
Journal:  Childs Nerv Syst       Date:  2020-08-04       Impact factor: 1.475

Review 9.  Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis.

Authors:  Ursula Basile; Giuseppe Cavallaro; Andrea Polistena; Sandra Giustini; Gennaro Orlando; Dario Cotesta; Luigi Petramala; Claudio Letizia; Stefano Calvieri; Giorgio De Toma
Journal:  J Gastrointest Surg       Date:  2010-01       Impact factor: 3.452

Review 10.  Update on the management of familial central nervous system tumor syndromes.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.